Literature DB >> 3223780

Oral contraceptives and focal nodular hyperplasia of the liver.

Z J Hagay1, R J Leiberman, M Katz, A Witznitzer.   

Abstract

A variety of benign liver tumors associated with the use of oral contraceptives has been described. However, there is controversy regarding the possible relation of focal nodular hyperplasia of the liver to oral contraceptive therapy. Over a ten-year period at the Soroka Medical Center, two young women were found to have hepatic tumors diagnosed as focal nodular hyperplasia. In both cases the hepatic nodules were an incidental finding at laparotomy and were thought to be metastatic tumors. The clinical and pathological findings in both cases are reported. The features of focal nodular hyperplasia and its possible relation to oral contraceptive use is discussed.

Entities:  

Keywords:  Asia; Biology; Case Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Developed Countries; Diseases; Endocrine System; Enzymes; Enzymes And Enzyme Inhibitors; Ethinyl Estradiol; Family Planning; Gynecologic Surgery; Hormones--side effects; Hysterectomy; Israel; Laparotomy; Levonorgestrel; Liver Neoplasms; Mediterranean Countries; Neoplasms; Oral Contraceptives--side effects; Ovariectomy; Physiology; Proteins; Research Methodology; Studies; Surgery; Treatment; Urogenital Surgery; Western Asia

Mesh:

Substances:

Year:  1988        PMID: 3223780     DOI: 10.1007/bf00932273

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  19 in total

1.  Focal nodular hyperplasia and liver cell adenoma: radiologic and pathologic differentiation.

Authors:  W J Casarella; D M Knowles; M Wolff; P M Johnson
Journal:  AJR Am J Roentgenol       Date:  1978-09       Impact factor: 3.959

2.  Benign tumors of the liver.

Authors:  K G Ishak; L Rabin
Journal:  Med Clin North Am       Date:  1975-07       Impact factor: 5.456

3.  Hepatic adenomas and oral contraceptives.

Authors:  S Sherlock
Journal:  Gut       Date:  1975-09       Impact factor: 23.059

4.  Letter: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives.

Authors:  D Ross; J Pina; M Mirza; A Galvan; L Ponce
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

5.  Focal nodular hyperplasia of the liver. Possible relationship to oral contraceptives.

Authors:  E T Mays; W M Christopherson; G H Barrows
Journal:  Am J Clin Pathol       Date:  1974-06       Impact factor: 2.493

6.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

7.  Experience with benign tumors of the liver.

Authors:  R A Malt; R A Hershberg; W L Miller
Journal:  Surg Gynecol Obstet       Date:  1970-02

8.  Minimal deviation hepatoma. A new entity.

Authors:  S J Galloway; W J Casarella; R Lattes; W B Seamam
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-09

9.  Focal nodular hyperplasia and hepatic adenoma: a review of eight cases in the pediatric age group.

Authors:  E E Lack; K Ornvold
Journal:  J Surg Oncol       Date:  1986-10       Impact factor: 3.454

10.  Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver.

Authors:  L D Scott; A R Katz; J H Duke; D F Cowan; N F Maklad
Journal:  JAMA       Date:  1984-03-16       Impact factor: 56.272

View more
  2 in total

Review 1.  Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports.

Authors:  Judith U Cope; Gregory H Reaman; Joseph M Tonning
Journal:  Sarcoma       Date:  2015-05-07

2.  Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury.

Authors:  Hira Imad Cheema; Ashutosh Gupta
Journal:  Case Rep Gastroenterol       Date:  2017-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.